Integra LifeSciences launches DuraGen Plus Dural Regeneration Matrix - Spinal Matrix

Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix, an absorbable and sutureless collagen onlay indicated as a dura substitute for the repair of dura mater.

Integra developed the first onlay collagen graft for dural repair in 1999 and is the market leader in providing graft materials for sutureless closure of dural defects in the United States.

The dura mater is a tough, fibrous membrane that surrounds and protects the tissues of the brain and spinal cord. When the dura mater is cut or torn, it must be repaired, either by suturing or applying a dural graft, to prevent cerebrospinal fluid (CSF) leaks. Dural defects may be repaired using several techniques, including commercially available dural graft substitutes. Surgeons may be able to repair the dura mater more efficiently when using graft substitutes that do not require sutures, such as DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix.

"DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix demonstrates Integra's ongoing commitment to provide surgeons with the most innovative technology, help increase confidence in patient treatment, and save valuable time in the operating room," said John Winge, Executive VP, Sales and Marketing, Integra Spine.

The DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix is distributed by Integra Spine's independent distributor network. Integra Spine is a leading provider of fusion implants and orthobiologics products.